Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications.

导出 OA

翻译打印收藏纠错

作者： Peter,Rambau ^[1] ; Linda E,Kelemen ^[2] ; Helen,Steed ^[3] ; May Lynn,Quan ^[4] ; Prafull,Ghatage ^[5] ; Martin,Köbel ^[6]

作者单位： Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB T2N 2T9, Canada. peter.rambau@ucalgary.ca. ^[1] Department of Pathology, Catholic University of Health and Allied Sciences, P.O. Box 1464, Mwanza, Tanzania. peter.rambau@ucalgary.ca. ^[2] Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. lkelemen@post.harvard.edu. ^[3] Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA. lkelemen@post.harvard.edu. ^[4] Department of Obstetrics and Gynecology, University of Alberta, Edmonton, AB T5H 3V9, Canada. Helen.Steed@albertahealthservices.ca. ^[5] Division of General Surgery and Surgical Oncology, University of Calgary, Calgary, AB T2N 2T9, Canada. MayLynn.Quan@albertahealthservices.ca. ^[6] Department of Gynecological Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB T2N 2T9, Canada. Prafull.Ghatage@albertahealthservices.ca. ^[7] Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB T2N 2T9, Canada. martin.koebel@cls.ab.ca. ^[8]

关键词 endometrioid estrogen receptor hormonal therapy ovarian cancer progesterone receptor prognosis